Fatal Kounis syndrome with stent thrombosis secondary to amoxicillin/clavulanic acid use: A case report and literature review.
Anaphylactic reactions are often induced by drugs, and the most frequent ones are penicillin derivates. The concurrence of acute coronary syndrome with hypersensitivity and anaphylactic or anaphylactoid reactions constitutes the Kounis syndrome. We report a case of a coronary stent thrombosis with a fatal outcome complicating an anaphylactic shock induced by amoxicillin-clavulanic acid association. A 58-year-old woman with a history of triple coronary stenting was treated by amoxicillin/clavulanic acid association for pharyngitis. One hour after the first drug intake, she developed an anaphylactic shock with acute constricting chest pain. She received intravenous hydrocortisone and was transferred to emergency department. The patient received epinephrine intravenously with fluid perfusion and oxygen. Electrocardiogram showed Pardee waves in the anterior precordial leads. Cardiac enzyme levels (troponin I) were disturbed. The patient was transferred to the coronary care unit with a diagnosis of acute myocardial infarction. The coronary angiography revealed anterior interventricular stent thrombosis. The patient experienced a cardiogenic shock with an important hemodynamic repercussion, and she died few hours later despite emergency care. The responsibility of amoxicillin-clavulanic acid association was retained in the genesis of this anaphylactic shock in front of a suggestive delay, a compatible evolution and a high semiotic score. Amoxicillin/clavulanic acid use may cause Kounis syndrome. The use of epinephrine is a challenging decision. We suggest that Kounis syndrome should be considered in the differential diagnosis of acute coronary syndrome.
Centre national de pharmacovigilance, 9, rue Dr Zouhaier-Essafi, 1006 Tunis, Tunisia. Electronic address: i.salouage@gmail.com.
Issam
I
Salouage
Centre national de pharmacovigilance, 9, rue Dr Zouhaier-Essafi, 1006 Tunis, Tunisia.
Sihem
S
El Aidli
Centre national de pharmacovigilance, 9, rue Dr Zouhaier-Essafi, 1006 Tunis, Tunisia.
Sarra
S
Kastalli
Centre national de pharmacovigilance, 9, rue Dr Zouhaier-Essafi, 1006 Tunis, Tunisia.
Riadh
R
Daghfous
Centre national de pharmacovigilance, 9, rue Dr Zouhaier-Essafi, 1006 Tunis, Tunisia.
Mohamed
M
Lakhal
Amoxicillin; Amoxicilline; Anaphylactic shock; Choc anaphylactique; Kounis syndrome; Stent thrombosis; Syndrome de Kounis; Thrombose de stent